GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » E10

Biostar Pharmaceuticals (Biostar Pharmaceuticals) E10 : $1.09 (As of Sep. 2017)


View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biostar Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2017 was $-0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.09 for the trailing ten years ended in Sep. 2017.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-29), Biostar Pharmaceuticals's current stock price is $0.0001. Biostar Pharmaceuticals's E10 for the quarter that ended in Sep. 2017 was $1.09. Biostar Pharmaceuticals's Shiller PE Ratio of today is 0.00.


Biostar Pharmaceuticals E10 Historical Data

The historical data trend for Biostar Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostar Pharmaceuticals E10 Chart

Biostar Pharmaceuticals Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biostar Pharmaceuticals Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.28 1.09

Competitive Comparison of Biostar Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Biostar Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biostar Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biostar Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biostar Pharmaceuticals's Shiller PE Ratio falls into.



Biostar Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biostar Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2017 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2017 (Change)*Current CPI (Sep. 2017)
=-0.05/104.1000*104.1000
=-0.050

Current CPI (Sep. 2017) = 104.1000.

Biostar Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
200712 0.840 82.911 1.055
200803 1.680 85.485 2.046
200806 1.680 85.058 2.056
200809 0.420 85.057 0.514
200812 0.840 83.956 1.042
200903 1.680 84.457 2.071
200906 3.360 83.615 4.183
200909 2.730 84.369 3.368
200912 -1.050 85.386 -1.280
201003 1.680 86.316 2.026
201006 4.200 85.886 5.091
201009 2.730 87.267 3.257
201012 4.620 89.289 5.386
201103 2.098 91.154 2.396
201106 3.150 91.612 3.579
201109 3.290 92.711 3.694
201112 0.630 92.885 0.706
201203 1.610 94.367 1.776
201206 -7.070 93.495 -7.872
201209 -4.410 94.482 -4.859
201212 -4.760 95.237 -5.203
201303 0.420 96.372 0.454
201306 -0.420 95.984 -0.456
201309 0.210 97.332 0.225
201312 0.350 97.624 0.373
201403 0.140 98.600 0.148
201406 0.770 98.200 0.816
201409 0.140 98.900 0.147
201412 1.250 99.000 1.314
201503 -0.070 99.900 -0.073
201506 -0.220 99.500 -0.230
201509 -0.570 100.500 -0.590
201512 -10.540 100.600 -10.907
201603 -0.280 102.200 -0.285
201606 -3.120 101.400 -3.203
201609 -0.710 102.400 -0.722
201612 1.610 102.600 1.634
201703 -0.380 103.200 -0.383
201706 -0.500 103.100 -0.505
201709 -0.050 104.100 -0.050

Add all the adjusted EPS together and divide 10 will get our e10.


Biostar Pharmaceuticals  (OTCPK:BSPM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biostar Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.0001/1.09
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biostar Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046
Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines